SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Guilford (GLFD) - Steadily Rising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DOUBLE who wrote (3)6/21/1996 5:17:00 PM
From: DAVID HU   of 496
 
Hi Double, (is this a real name?)

I thought the price drop was due to 1) profit taking and 2) the approval of Gliadel was given to reccurent tumor but not initial cases. The company is developing an imaging chemical (phase II) and has recently been given a strong buy by Alex Brown. Could you elaborate what do you mean most significant indications and what FDA wants more.
Thanks in advance.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News